These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14702622)

  • 21. Production of anti-epithelial antibodies and acantholysis by vaccination with an anti-idiotypic antibody, mimicking desmoglein 1.
    Avalos-Díaz E; López-Robles E; Alvarado-Flores E; Herrera-Esparza R
    Exp Dermatol; 2008 Jan; 17(1):44-8. PubMed ID: 18095944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.
    Erlandsson A; Eriksson D; Johansson L; Riklund K; Stigbrand T; Sundström BE
    Mol Immunol; 2006 Feb; 43(6):599-606. PubMed ID: 15978666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease].
    Matusiewicz K; Iwańczak B; Matusiewicz M; Iwańczak F
    Pol Merkur Lekarski; 2006 Jan; 20(115):17-21. PubMed ID: 16617728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Booster immunization of antigen primed mice with anti-idiotypic T cells generates antigen-specific memory T cell response.
    Lal G; Shaila MS; Nayak R
    Vaccine; 2006 Feb; 24(8):1149-58. PubMed ID: 16239053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
    Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
    Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
    Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
    Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionally fused antibodies--a novel adjuvant fusion system.
    Larsen M; Jensen KB; Christensen PA; Suarez E; Paris D; Sanz L; Ravn P; Sauce D; Saas P; Goletz S; Alvarez-Vallina L; Kristensen P
    J Immunol Methods; 2008 Dec; 339(2):220-7. PubMed ID: 18854189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20.
    Hong K; Presta LG; Lu Y; Penn A; Adams C; Chuntharapai A; Yang J; Wong WL; Meng YG
    J Immunol Methods; 2004 Nov; 294(1-2):189-97. PubMed ID: 15604027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meeting of mimics.
    Beninati C; Teti G
    Trends Microbiol; 2000 Nov; 8(11):492-3. PubMed ID: 11126442
    [No Abstract]   [Full Text] [Related]  

  • 32. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
    Li AD; Li Z; Wang YH; Zhang YM; Ma J
    Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.
    Presta LG
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):640-56. PubMed ID: 16904789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies.
    Zhang W; Reichlin M
    Clin Immunol; 2005 Feb; 114(2):130-6. PubMed ID: 15639646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative human monoclonal antibody immunoassay using anti-idiotypic antibody as a membrane antigen surrogate with surface-plasmon-resonance detection.
    Wong RB; Lee AH; Rangan VS; Cheng KC
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):51-61. PubMed ID: 18680480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic complementarity in the induction of autoimmunity: a general theory and review.
    Root-Bernstein R
    Autoimmun Rev; 2007 Apr; 6(5):272-7. PubMed ID: 17412297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human anti-immunoglobulin antibodies interfering in immunometric assays.
    Bjerner J
    Scand J Clin Lab Invest; 2005; 65(5):349-64. PubMed ID: 16081358
    [No Abstract]   [Full Text] [Related]  

  • 39. Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting.
    Missailidis S; Thomaidou D; Borbas KE; Price MR
    J Immunol Methods; 2005 Jan; 296(1-2):45-62. PubMed ID: 15680150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Noncompetitive immunoenzymometric assays for a hapten molecule employing anti-idiotype antibodies].
    Niwa T; Kobayashi N; Goto J
    Rinsho Byori; 2008 Jun; 56(6):536-43. PubMed ID: 18646639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.